(Q50303730)

2 March 2018

title

Use of methylphenidate in the treatment of children with autistic disorder. (English)

1 reference

2 March 2018

0 references

H Quintana

1

1 reference

2 March 2018

B Birmaher

2

1 reference

2 March 2018

D Stedge

3

1 reference

2 March 2018

S Lennon

4

1 reference

2 March 2018

J Freed

5

1 reference

2 March 2018

J Bridge

6

1 reference

2 March 2018

L Greenhill

7

1 reference

2 March 2018

language of work or name

English

0 references

publication date

1 June 1995

1 reference

2 March 2018

Journal of Autism and Developmental Disorders

published in

1 reference

2 March 2018

volume

25

1 reference

2 March 2018

page(s)

283-294

1 reference

2 March 2018

issue

3

1 reference

2 March 2018

https://scigraph.springernature.com/pub.10.1007/bf02179289

exact match

0 references

cites work

Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms.

1 reference

https://api.crossref.org/works/10.1007%2FBF02179289

Coexistence of childhood onset pervasive developmental disorder and attention deficit disorder with hyperactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02179289

A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02179289

Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02179289

CASE STUDY Methylphenidate Treatment of Hyperactive Autistic Children

21 January 2018

1 reference

12 December 2020

The use of methylphenidate in autism.

1 reference

12 December 2020

Stimulant medication in certain childhood disorders.

1 reference

12 December 2020

Normative data on revised Conners Parent and Teacher Rating Scales

1 reference

12 December 2020

Tardive dyskinesia and other movement disorders in children treated with psychotropic drugs.

1 reference

12 December 2020

A Comparison of Haloperidol and Behavior Therapy and Their Interaction in Autistic Children

1 reference

12 December 2020

Naltrexone in autistic children: a double-blind and placebo-controlled study

1 reference

12 December 2020

Randomized Trial of Methylphenidate for an Autistic Child

1 reference

12 December 2020

Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate

1 reference

12 December 2020

Naltrexone in autistic children: behavioral symptoms and attentional learning

1 reference

12 December 2020

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children

1 reference

12 December 2020

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children

1 reference

12 December 2020

Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.

1 reference

12 December 2020

Initial Anticholinergic Prophylaxis for Neuroleptic-Induced Extrapyramidal Syndromes

1 reference

12 December 2020

The Effects of Methylphenidate on Early Infantile Autism and Its Relation to Serum Serotonin Levels

1 reference

12 December 2020

1 reference

12 December 2020

Tardive and withdrawal dyskinesia in autistic children: a prospective study.

1 reference

12 December 2020

Clomipramine in autism: preliminary evidence of efficacy

1 reference

12 December 2020

Use of medication in pervasive developmental disorders

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02179289

1 reference

2 March 2018

release_jb2s4e3lxvb25juxqhpshfwk3q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jb2s4e3lxvb25juxqhpshfwk3q

24 November 2022

mapped directly with Wikidata item

PubMed ID

7559293

1 reference

2 March 2018